Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Aman Chauhan, MD, MBBS

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Address654 Minnesota Street
San Francisco CA 94107
PronounsHe/Him/His
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Phase 2 study of cabozantinib (XL184) with nivolumab and ipilimumab for the treatment of poorly differentiated neuroendocrine carcinomas (ETCTN10315). Oncologist. 2026 May 08; 31(6). Mandl A, Chen R, Das S, Strosberg JR, Kasi A, Konda B, Li D, Burns TF, Chauhan A, Ciombor KK, Dayyani F, Dorff T, Ohr JP, Patel BB, Sukrithan V, Soares HP, Chen K, Liu SV, Tesfaye AA, Carducci MA, Beumer JH. PMID: 41968073.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    2. The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate Cancer, and Beyond. J Nucl Med. 2026 Apr 30. Chauhan A, Hendifar AE, El-Haddad G, Soares HP, Herrmann K. PMID: 42061947.
      View in: PubMed   Mentions:    Fields:    
    3. The genomic, transcriptomic, and immunologic landscape of TEM8 (ANTXR1) in neuroendocrine neoplasms (NENs) including small-cell lung cancer (SCLC). Cancer Treat Res Commun. 2026 Mar 22; 47:101190. Kareff SA, Krause H, Elliott A, Samec T, Lopes G, Hosein PJ, Jani CT, Lou E, Soares H, Magistri M, Sumarriva D, Oberley M, Chauhan A. PMID: 42061011.
      View in: PubMed   Mentions:    Fields:    
    4. Dethroning of Neuroendocrine Tumor as an Orphan Disease: US Incidence, Prevalence, and Survival in the 21st Century. Cancers (Basel). 2025 Oct 15; 17(20). Yu Q, Cao F, Hosein P, Huang B, Pinheiro PS, Wang Y, Del Rivero J, Lopes G, Chauhan A. PMID: 41154379; PMCID: PMC12563563.
      View in: PubMed   Mentions: 1  
    5. Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline. JCO Oncol Pract. 2026 Jan; 22(1):19-35. Perez K, Del Rivero J, Kennedy EB, Basu S, Chauhan A, Connolly HM, Dasari AN, Gangi A, Clarke CN, Hallet J, Howe JR, Grady E, Ivanidze J, Mittra ES, White SB, Raj NP, Vijayvergia N, Lewis MA, Chan JA, Kunz PL, Mailman J, Arshad J, Soares HP, Singh S, Chandrasekharan C, Soulen MC, Janson ET, Halfdanarson TR, Strosberg JR, Bergsland EK. PMID: 40344544.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    6. Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1). J Immunother Cancer. 2024 Nov 20; 12(11). Vaishampayan UN, Muzaffar J, Winer I, Rosen SD, Hoimes CJ, Chauhan A, Spreafico A, Lewis KD, Bruno DS, Dumas O, McDermott DF, Strauss JF, Chu QS, Gilbert L, Chaudhry A, Calvo E, Dalal R, Boni V, Ernstoff MS, Velcheti V. PMID: 39567211; PMCID: PMC11580269.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    7. Leveraging Programmatic Collaboration for a Radiopharmaceutical Clinic. Cancers (Basel). 2024 Apr 02; 16(7). Kunos CA, Martin ME, Georgiou MF, Kuker RA, Chauhan A. PMID: 38611074; PMCID: PMC11011188.
      View in: PubMed   Mentions: 1  
    8. Development and validation of a chromatin regulator signature for predicting prognosis hepatocellular carcinoma patient. J Gastrointest Oncol. 2024 Feb 29; 15(1):397-414. Mao J, Song F, Zhang Y, Li Y, Inchingolo R, Chauhan A, Midorikawa Y, Chen Z, Tang W. PMID: 38482221; PMCID: PMC10932653.
      View in: PubMed   Mentions: 3  
    9. Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical Trial. JAMA Oncol. 2023 12 01; 9(12):1669-1677. Takahashi N, Hao Z, Villaruz LC, Zhang J, Ruiz J, Petty WJ, Mamdani H, Riess JW, Nieva J, Pachecho JM, Fuld AD, Shum E, Chauhan A, Nichols S, Shimellis H, McGlone J, Sciuto L, Pinkiert D, Graham C, Shelat M, Kattappuram R, Abel M, Schroeder B, Upadhyay D, Krishnamurthy M, Sharma AK, Kumar R, Malin J, Schultz CW, Goyal S, Redon CE, Pommier Y, Aladjem MI, Gore SD, Steinberg SM, Vilimas R, Desai P, Thomas A. PMID: 37824137; PMCID: PMC10570917.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    10. Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline. J Clin Oncol. 2023 11 10; 41(32):5049-5067. Del Rivero J, Perez K, Kennedy EB, Mittra ES, Vijayvergia N, Arshad J, Basu S, Chauhan A, Dasari AN, Bellizzi AM, Gangi A, Grady E, Howe JR, Ivanidze J, Lewis M, Mailman J, Raj N, Soares HP, Soulen MC, White SB, Chan JA, Kunz PL, Singh S, Halfdanarson TR, Strosberg JR, Bergsland EK. PMID: 37774329.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    11. Review of practice informing data and current state of NCCN consensus guidelines in hepatobiliary cancers. Hepatobiliary Surg Nutr. 2023 Oct 01; 12(5):798-803. Corbett V, Li D, Chauhan A. PMID: 37886197; PMCID: PMC10598301.
      View in: PubMed   Mentions: 2  
    12. Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting. J Natl Cancer Inst. 2023 09 07; 115(9):1001-1010. Singh S, Hope TA, Bergsland EB, Bodei L, Bushnell DL, Chan JA, Chasen BR, Chauhan A, Das S, Dasari A, Del Rivero J, El-Haddad G, Goodman KA, Halperin DM, Lewis MA, Lindwasser OW, Myrehaug S, Raj NP, Reidy-Lagunes DL, Soares HP, Strosberg JR, Kohn EC, Kunz PL, NET CTPM participants . PMID: 37255328; PMCID: PMC10483264.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    13. Pulmonary large cell neuroendocrine carcinoma (LCNEC): a population-based study addressing recent molecular-genetic advances and emerging therapeutic approaches. Clin Exp Med. 2023 Nov; 23(7):3947-3955. Khan J, Yasinzai AQK, Matosz S, Khan M, Heneidi S, Mesa H, Chauhan A, Del Rivero J, Karim NA, Ullah A. PMID: 37060529.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    14. Treatment Sequencing Strategies in Advanced Neuroendocrine Tumors: A Review. Cancers (Basel). 2022 Oct 26; 14(21). Chauhan A, Del Rivero J, Ramirez RA, Soares HP, Li D. PMID: 36358667; PMCID: PMC9656186.
      View in: PubMed   Mentions: 12  
    15. An Update on the Management of Mixed Neuroendocrine-Non-neuroendocrine Neoplasms (MiNEN). Curr Treat Options Oncol. 2022 05; 23(5):721-735. Jacob A, Raj R, Allison DB, Soares HP, Chauhan A. PMID: 35347561.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    16. Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma. Front Oncol. 2021; 11:653153. Saghaeiannejad Esfahani H, Vela CM, Chauhan A. PMID: 34141612; PMCID: PMC8203494.
      View in: PubMed   Mentions: 14  
    17. Radiopharmaceutical Validation for Clinical Use. Front Oncol. 2021; 11:630827. Kunos CA, Howells R, Chauhan A, Myint ZW, Bernard ME, El Khouli R, Capala J. PMID: 33747951; PMCID: PMC7966985.
      View in: PubMed   Mentions: 12  
    18. 68Ga-DOTATATE PET/CT: The Optimum Standardized Uptake Value (SUV) Internal Reference. Acad Radiol. 2022 01; 29(1):95-106. Ragab A, Wu J, Ding X, Clark A, Mischen B, Chauhan A, Oates ME, Anthony L, El Khouli R. PMID: 34756348.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    Aman's Networks
    Concepts (46)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (5)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-22-g09c84f92 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.